Description

DSIP is a synthetic long-acting analog of the naturally occurring hormone amylin. Laboratory research involving Cagrilintide explores its potential effects on appetite regulation, energy balance, and weight management. Studies suggest that Cagrilintide may modulate satiety signals and gastrointestinal motility, influencing food intake and energy consumption pathways.

Scientific investigations are actively examining Cagrilintide’s potential impacts on metabolic processes, particularly related to obesity, appetite control, and energy homeostasis in laboratory settings.